ECCMID 25th (2015)

Title Content type
Successful treatment of contaminated epidural steroid associated fungal meningitis with Isavuconazole (click for details)
An open-label phase 3 study of Isavuconazole (VITAL): focus on patients with mixed fungal infections (click for details)
Drug interaction profiles of Isavuconazole, voriconazole and posaconazole with immunosuppressants metabolized by CYP4503A4 (CYP3A4) – (click for details)
A comparison of the safety profiles of Isavuconazole vs voriconazole in the phase 3 SECURE study in patients with invasive mould infections – (click for details)
Safety and outcomes in invasive aspergillosis patients with renal vs. no renal impairment treated with Isavuconazole: experience from the SECURE (randomized) and VITAL trials (click for details)
Safety and outcomes in obese patients with invasive fungal disease treated with Isavuconazole in the phase 3 randomised double-blind SECURE trial – (click for details)
Outcome of invasive aspergillosis after allogeneic haematopoietic stemcell transplantation in patientswith invasive aspergillosis before transplantation (click for details)
Prediction of survival in patients with invasive pulmonary aspergillosis using volumetric analysis of computed tomography scans, galactomannan and absolute neutrophil count (click for details)
The inhibitory effect of Pseudomonas aeruginosa on the growth of Aspergillus strains (click for details)
Hypoxia and hyperthermia in combination influence the immune response of human dendritic cells against Aspergillus fumigatus (click for details)


Subscribe to ECCMID 25th (2015)